Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase I studies of AVE-9633, AVE-1642 reported

Dec. 20, 2007

Dual Akt/p70S6K inhibitor effective against multiple myeloma in vitro

Dec. 19, 2007

DCC-2036 shows preclinical antileukemic activity against drug-resistant CML

Dec. 19, 2007

Increased survival in mouse models of multiple myeloma with Prolexys' new compound

Dec. 19, 2007

SONOMA-2 shows effect of alfimeprase on occluded central venous access devices

Dec. 19, 2007

Wyeth Pharmaceuticals reports positive results from two phase III clinical studies of Pristiq

Dec. 18, 2007

Phase II data on VNP-40101M in elderly AML patients reported

Dec. 18, 2007

Signs of activity seen with CPX-351 in leukemia, myelodysplastic syndrome

Dec. 18, 2007

A DYRK3 inhibitor shows potential for anemia therapy

Dec. 18, 2007

Activity of obatoclax investigated in multiple studies

Dec. 17, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...